Free Trial
NASDAQ:HCM

HUTCHMED (HCM) Stock Price, News & Analysis

HUTCHMED logo
$15.89 +0.20 (+1.30%)
Closing price 07/3/2025 01:18 PM Eastern
Extended Trading
$15.94 +0.04 (+0.26%)
As of 07/3/2025 04:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About HUTCHMED Stock (NASDAQ:HCM)

Key Stats

Today's Range
$15.57
$15.95
50-Day Range
$13.09
$17.72
52-Week Range
$11.51
$21.50
Volume
59,320 shs
Average Volume
101,147 shs
Market Capitalization
$2.77 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$19.00
Consensus Rating
Hold

Company Overview

HUTCHMED Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
27th Percentile Overall Score

HCM MarketRank™: 

HUTCHMED scored higher than 27% of companies evaluated by MarketBeat, and ranked 705th out of 929 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    HUTCHMED has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    HUTCHMED has only been the subject of 1 research reports in the past 90 days.

  • Read more about HUTCHMED's stock forecast and price target.
  • Earnings Growth

    Earnings for HUTCHMED are expected to grow by 812.50% in the coming year, from $0.16 to $1.46 per share.

  • Price to Book Value per Share Ratio

    HUTCHMED has a P/B Ratio of 3.59. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.26% of the float of HUTCHMED has been sold short.
  • Short Interest Ratio / Days to Cover

    HUTCHMED has a short interest ratio ("days to cover") of 4.7.
  • Change versus previous month

    Short interest in HUTCHMED has recently decreased by 7.70%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    HUTCHMED does not currently pay a dividend.

  • Dividend Growth

    HUTCHMED does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.26% of the float of HUTCHMED has been sold short.
  • Short Interest Ratio / Days to Cover

    HUTCHMED has a short interest ratio ("days to cover") of 4.7.
  • Change versus previous month

    Short interest in HUTCHMED has recently decreased by 7.70%, indicating that investor sentiment is improving significantly.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for HUTCHMED this week, compared to 3 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, HUTCHMED insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 3.60% of the stock of HUTCHMED is held by insiders.

  • Percentage Held by Institutions

    Only 8.82% of the stock of HUTCHMED is held by institutions.

  • Read more about HUTCHMED's insider trading history.
Receive HCM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HUTCHMED and its competitors with MarketBeat's FREE daily newsletter.

HCM Stock News Headlines

HUTCHMED to Announce 2025 Half-Year Financial Results
$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.
HUTCHMED (NASDAQ:HCM) Stock Rating Upgraded by Wall Street Zen
HUTCHMED (China) Limited (HCM.L) - Yahoo Finance
HUTCHMED (China) Limited (HCM) - Yahoo Finance
See More Headlines

HCM Stock Analysis - Frequently Asked Questions

HUTCHMED's stock was trading at $14.41 at the start of the year. Since then, HCM shares have increased by 10.3% and is now trading at $15.8940.

HUTCHMED (HCM) raised $100 million in an IPO on Thursday, March 17th 2016. The company issued 6,100,000 shares at $16.33 per share. BofA Merrill Lynch and Deutsche Bank Securities acted as the underwriters for the IPO and Stifel, Canaccord Genuity, Panmure Gordon and CITIC CLSA were co-managers.

Shares of HCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that HUTCHMED investors own include NVIDIA (NVDA), Broadcom (AVGO), Adobe (ADBE), Meta Platforms (META), Arista Networks (ANET), GE Aerospace (GE) and ServiceNow (NOW).

Company Calendar

Today
7/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:HCM
Employees
1,811
Year Founded
2000

Price Target and Rating

Average Stock Price Target
$19.00
High Stock Price Target
$19.00
Low Stock Price Target
$19.00
Potential Upside/Downside
+19.5%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$630.20 million
Cash Flow
$0.29 per share
Price / Cash Flow
55.04
Book Value
$4.43 per share
Price / Book
3.59

Miscellaneous

Free Float
168,046,000
Market Cap
$2.77 billion
Optionable
Not Optionable
Beta
0.52

Social Links

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:HCM) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners